Samuel Kintz - 08 Oct 2024 Form 4 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Signature
/s/ Ben Hohl, by power of attorney
Issuer symbol
ELVN
Transactions as of
08 Oct 2024
Transactions value $
-$841,334
Form type
4
Filing time
10 Oct 2024, 20:38:22 UTC
Previous filing
08 Oct 2024
Next filing
22 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELVN Common Stock Sale -$368K -13.2K -1.27% $27.95 1.02M 08 Oct 2024 See footnote F1, F2, F3
transaction ELVN Common Stock Sale -$2.85K -100 -0.01% $28.51 1.02M 08 Oct 2024 See footnote F1, F3
transaction ELVN Common Stock Sale -$390K -13.9K -1.36% $28.07 1.01M 09 Oct 2024 See footnote F1, F3, F4
transaction ELVN Common Stock Sale -$80.7K -2.83K -0.28% $28.53 1M 09 Oct 2024 See footnote F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $27.50 to $28.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.
F4 This transaction was executed in multiple trades at prices ranging from $27.50 to $28.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $28.51to $28.56. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.